Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization
Shannon L. Werner, Ryon P. Graf, Mark Landers, et al.
Journal of Circulating Biomarkers (2015) Vol. 4, pp. 3-3
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
Howard I. Scher, David Lu, Nicole A. Schreiber, et al.
JAMA Oncology (2016) Vol. 2, Iss. 11, pp. 1441-1441
Open Access | Times Cited: 587
Challenges in circulating tumor cell detection by the CellSearch system
Kiki Andree, Guus van Dalum, Leon W.M.M. Terstappen
Molecular Oncology (2015) Vol. 10, Iss. 3, pp. 395-407
Open Access | Times Cited: 294
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
Elaine Kilgour, Dominic G. Rothwell, Ged Brady, et al.
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 485-495
Open Access | Times Cited: 285
Circulating biomarkers for early detection and clinical management of colorectal cancer
María Marcuello, Veronika Vymetálková, Rui P. Neves, et al.
Molecular Aspects of Medicine (2019) Vol. 69, pp. 107-122
Open Access | Times Cited: 238
Profiling circulating tumour cells and other biomarkers of invasive cancers
Mahla Poudineh, Edward H. Sargent, Klaus Pantel, et al.
Nature Biomedical Engineering (2018) Vol. 2, Iss. 2, pp. 72-84
Closed Access | Times Cited: 224
Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?
Paul Hofman, Simon Heeke, Catherine Alix‐Panabières, et al.
Annals of Oncology (2019) Vol. 30, Iss. 9, pp. 1448-1459
Open Access | Times Cited: 168
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
Loredana Puca, Katie Gavyert, Verena Sailer, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 484
Open Access | Times Cited: 162
New insights into the correlations between circulating tumor cells and target organ metastasis
Qinru Zhan, Bixia Liu, Xiaohua Situ, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 54
Recent Advances in Methods for Circulating Tumor Cell Detection
Monika Vidlarova, Alona Řehulková, Pavel Stejskal, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3902-3902
Open Access | Times Cited: 43
Circulating tumor cells as liquid biopsy markers in cancer patients
Daniel J. Smit, Klaus Pantel
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101258-101258
Open Access | Times Cited: 19
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product
Avanish Mishra, Shih‐Bo Huang, Taronish D. Dubash, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer
Howard I. Scher, Ryon P. Graf, Nicole A. Schreiber, et al.
European Urology (2016) Vol. 71, Iss. 6, pp. 874-882
Open Access | Times Cited: 164
Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells
Joshua M. Jackson, Małgorzata A. Witek, Joyce W. Kamande, et al.
Chemical Society Reviews (2017) Vol. 46, Iss. 14, pp. 4245-4280
Open Access | Times Cited: 156
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer
Karim Boudadi, Daniel L. Suzman, Valsamo Anagnostou, et al.
Oncotarget (2018) Vol. 9, Iss. 47, pp. 28561-28571
Open Access | Times Cited: 146
Current approaches for avoiding the limitations of circulating tumor cells detection methods—implications for diagnosis and treatment of patients with solid tumors
Artur Kowalik, Magdalena Kowalewska, Stanisław Góźdż
Translational research (2017) Vol. 185, pp. 58-84.e15
Open Access | Times Cited: 141
Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine
Giovanna Rossi, Michail Ignatiadis
Cancer Research (2019) Vol. 79, Iss. 11, pp. 2798-2804
Open Access | Times Cited: 134
The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer
Himisha Beltran, Adam Jendrisak, Mark Landers, et al.
Clinical Cancer Research (2015) Vol. 22, Iss. 6, pp. 1510-1519
Open Access | Times Cited: 128
Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer
Howard I. Scher, Ryon P. Graf, Nicole A. Schreiber, et al.
Cancer Research (2017) Vol. 77, Iss. 20, pp. 5687-5698
Open Access | Times Cited: 127
Circulating Tumor Cells: Moving Biological Insights into Detection
Lichan Chen, Ann M. Bode, Zigang Dong
Theranostics (2017) Vol. 7, Iss. 10, pp. 2606-2619
Open Access | Times Cited: 119
Technical challenges in the isolation and analysis of circulating tumor cells
Emma E. van der Toom, James E. Verdone, Michael A. Gorin, et al.
Oncotarget (2016) Vol. 7, Iss. 38, pp. 62754-62766
Open Access | Times Cited: 102
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
Archana Anantharaman, Terence W. Friedlander, David Lu, et al.
BMC Cancer (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 102
Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer
Michael A. Gorin, James E. Verdone, Emma van der Toom, et al.
Nature Reviews Urology (2016) Vol. 14, Iss. 2, pp. 90-97
Closed Access | Times Cited: 97
Review: Microfluidics technologies for blood-based cancer liquid biopsies
Yuxi Sun, Thomas A. Haglund, Aaron J. Rogers, et al.
Analytica Chimica Acta (2018) Vol. 1012, pp. 10-29
Closed Access | Times Cited: 94
Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors
Pamela Pinzani, Valeria D’Argenio, Marzia Del Re, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 7, pp. 1181-1200
Open Access | Times Cited: 92
Circulating Tumor Cells in Early Breast Cancer
Laura Thery, Alessandra Meddis, Luc Cabel, et al.
JNCI Cancer Spectrum (2019) Vol. 3, Iss. 2
Open Access | Times Cited: 84
Page 1 - Next Page

Scroll to top